MedTrace Logo

Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for AF

NCT04775264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-02-09

Study results available
· View outcomes & findings →

Summary

A prospective, single arm, multi-center exploratory study of safety and feasibility in the treatment of patients undergoing cardiothoracic surgery.

Conditions

Interventions

PROCEDURE

Pulsed Electric Field Ablation

Catheter ablation of Ganglionated Plexi (GP) structures on the epicardial surface of the heart during cardiothoracic surgery

Sponsors & Collaborators

  • Atrian Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Barry O'Brien, PhD · AtriAN Medical

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2022-06-17
Completion
2023-04-27

Countries

  • Czechia
  • Georgia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775264 on ClinicalTrials.gov